Abstract:Background Oxidative stress (OS) and neuroinflammatory pathways play an important role in the pathophysiology of schizophrenia. The present study investigated the relationship between OS, inflammatory cytokines, and clinical features in male patients with treatment-resistant schizophrenia (TRS). Method We measured plasma OS parameters, including manganese-superoxide dismutase (Mn-SOD), copper/zinc-containing SOD (CuZn-SOD), total-SOD (T-SOD), malondialdehyde (MDA), catalase (CAT), and glutathione peroxidase (GSH-Px); and serum inflammatory cytokines, including interleukin (IL)− 1α, IL-6, tumor necrosis factor-alpha (TNF-α), and interferon (IFN)-γ, from 80 male patients with chronic schizophrenia (31 had TRS and 49 had chronic stable schizophrenia (CSS)), and 42 healthy controls. The severity of psychotic symptoms was evaluated using the Positive and Negative Syndrome Scale (PANSS). Results Compared with healthy controls, plasma Mn-SOD, CuZn-SOD, T-SOD, GSH-Px, and MDA levels were significantly lower, while CAT and serum IL-6 levels were higher in both TRS and CSS male patients (all P < 0.05). Significant differences in the activities of CAT ( F = 6.068, P = 0.016) and IL-6 levels ( F = 6.876, P = 0.011) were observed between TRS and CSS male patients after analysis of covariance. Moreover, a significant positive correlation was found between IL-6 levels and PANSS general psychopathology subscores ( r = 0.485, P = 0.006) and between CAT activity and PANSS total scores ( r = 0.409, P = 0.022) in TRS male patients. CAT and IL-6 levels were predictors for TRS. Additionally, in chronic schizophrenia patients, a significant positive correlation was observed between IL-6 and GSH-Px ( r = 0.292, P = 0.012), and the interaction effect of IL-6 and GSH-Px was positively associated with PANSS general psychopathology scores ( r = 0.287, P = 0.014). Conclusion This preliminary study indicated that variations in OS and inflammatory cytokines may be involved in psychopathology for patients with chronic schizophrenia, especially in male patients with TRS.

Superoxide Dismutase and Cytokines in Chronic Patients with Schizophrenia: Association with Psychopathology and Response to Antipsychotics

Imbalanced Free Radicals and Antioxidant Defense Systems in Schizophrenia: A Comparative Study

Elevated activity of plasma superoxide dismutase in never-treated first-episode schizophrenia patients: Associated with depressive symptoms

Catalase and interleukin-6 serum elevation in a prediction of treatment-resistance in male schizophrenia patients

Serum Oxidative Stress Marker Levels in Unmedicated and Medicated Patients with Schizophrenia

Effects of Risperidone and Haloperidol on Superoxide Dismutase and Nitric Oxide in Schizophrenia

The Interplay Between BDNF and Oxidative Stress in Chronic Schizophrenia

Clinical Symptoms and Cognitive Impairment Associated with Male Schizophrenia Relate to Plasma Manganese Superoxide Dismutase Activity: a Case-Control Study.

Cortisol and Cytokines in Chronic and Treatment-Resistant Patients with Schizophrenia: Association with Psychopathology and Response to Antipsychotics

Elevated Blood Superoxide Dismutase in Neuroleptic-Free Schizophrenia: Association with Positive Symptoms

Effect of Risperidone Treatment on Serum Activity of Superoxide Dismutase and Levels of Malondialdehyde and S100B in First-Episode Schizophrenic Patients

Blood Superoxide Dismutase Level in Schizophrenic Patients with Tardive Dyskinesia: Association with Dyskinetic Movements

Variations to plasma H 2 O 2 levels and TAC in chronical medicated and treatment-resistant male schizophrenia patients: Correlations with psychopathology

Variations of plasma oxidative stress levels in male patients with chronic schizophrenia. Correlations with psychopathology and matrix metalloproteinase-9: a case-control study

Elevated activity of superoxide dismutase in male late-life schizophrenia and its correlation with clinical symptoms and cognitive deficits

Cognitive Impairment and Psychopathology Are Related to Plasma Oxidative Stress in Long Term Hospitalized Patients With Chronic Schizophrenia

The effect of risperidone treatment on superoxide dismutase in schizophrenia

Antioxidant Enzymes and Lipid Peroxidation in Different Forms of Schizophrenia Treated with Typical and Atypical Antipsychotics.

Sex Difference in the Interrelationship Between TNF-α and Oxidative Stress Status in First-Episode Drug-Naïve Schizophrenia.

Cognition Impairment in Schizophrenia Patients with Tardive Dyskinesia: Association with Plasma Superoxide Dismutase Activity.

Oxidative and Nitrosative Stress Biomarkers in Chronic Schizophrenia.